BACKGROUND: Reports documenting the use of extracorporeal membrane oxygenation (ECMO) after blunt @entity130 are scarce. We used a large, multicenter database to examine outcomes when ECMO was used in treating @entity1 with blunt @entity130 . METHODS: We performed a retrospective analysis of ECMO @entity1 in the Extracorporeal Life Support Organization database between 1998 and 2014. The diagnostic code for blunt @entity358 (861.21, DRG International Classification of Diseases-9th Rev.) was used to identify @entity1 treated with ECMO after blunt @entity130 . Variations of pre-ECMO respiratory support were also evaluated. The primary outcome was survival to discharge; the secondary outcome was @entity548 complication associated with ECMO. RESULTS: Eighty-five @entity1 met inclusion criteria. The mean    SEM age of the cohort was 28.9    1.1 years; 71 (83.5%) were male. The mean    SEM pre-ECMO PaO2/FIO2 ratio was 59.7    3.5, and the mean    SEM pre-ECMO length of ventilation was 94.7    13.2 hours. Pre-ECMO support included inhaled @entity842 (15 @entity1 , 17.6%), high-frequency oscillation (10, 11.8%), and vasopressor agents (57, 67.1%). The mean    SEM duration of ECMO was 207.4    23.8 hours, and 63 @entity1 (74.1%) were treated with venovenous ECMO. Thirty-two @entity1 (37.6%) underwent invasive procedures before ECMO, and 12 @entity1 (14.1%) underwent invasive procedures while on ECMO. @entity548 occurred in 25 cases (29.4%), including 12 @entity1 (14.1%) with surgical site @entity548 and 16 (18.8%) with cannula site @entity548 (6 @entity1 had both). The rate of survival to discharge was 74.1%. Multivariate analysis showed that shorter duration of ECMO and the use of venovenous ECMO predicted survival. CONCLUSION: Outcomes after the use of ECMO in blunt @entity130 can be favorable. Some @entity130 @entity1 are appropriate candidates for this therapy. Further study may discern which subpopulations of @entity130 @entity1 will benefit most from ECMO. LEVEL OF EVIDENCE: Therapeutic/care management study, level V.

The use of extracorporeal membrane oxygenation in blunt XXXX : A study of the Extracorporeal Life Support Organization database.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity548 :: ('MESH:D006470', 'Disease') :: ['hemorrhagic', 'Hemorrhagic complications', 'bleeding'] @entity358 :: ('MESH:D008171', 'Disease') :: ['pulmonary contusion'] @entity842 :: ('MESH:D009569', 'Chemical') :: ['nitric oxide'] @entity130 :: ('MESH:D014947', 'Disease') :: ['trauma', 'thoracic trauma']
@entity130 :: (MESH:D014947,Disease) :: ['thoracic trauma']
